Metraipolis › archive › dc_4e073a04611a

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease — Europe PMC PMID:41323967

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41323967
DOI
10.3389/fendo.2025.1695342
License (as archived)
solo-consultazione
Archived
2026-11-08T14:19:20.991Z
SHA-256 of the archived text
e410dc5a40b16dbeee769a3555b4762d70bc13f2c61e6a9724aa0b9ea0bc623a
Stable URL of this page
https://metraipolis.com/documento/dc_4e073a04611a

How to cite

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease — Europe PMC PMID:41323967 — Europe PMC (en), https://europepmc.org/article/MED/41323967 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e073a04611a (Metraipolis archive dc_4e073a04611a, sha256 e410dc5a40b16dbeee769a3555b4762d70bc13f2c61e6a9724aa0b9ea0bc623a)
BibTeX
@misc{dc4e073a04611a,
  title = {Real-life data on pasireotide in monotherapy or combined in active Cushing's disease — Europe PMC PMID:41323967},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41323967},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e073a04611a; sha256 e410dc5a40b16dbeee769a3555b4762d70bc13f2c61e6a9724aa0b9ea0bc623a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41323967. Agents can read the archived copy with the MCP tool read_document.